Tokyo Medical University Hachioji Medical Center
In research, Tokyo Medical University Hachioji Medical Center stands highest in Medicine (#7,324 of 10,443 worldwide) and Health Sciences (#9,111 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 7.5× its share of world research.
- World rank, 2022–2025
- #19,463 of 28,054 · #21,012 all time
- Rank in Japan
- #553 of 1,070
- Research works
- 1.1k ▲ 21% vs 2013–17
- Citations
- 10k 9.1 per fractional work
- Top-10% rate
- 5.0% record average 16.5%
- Open access
- 52% world 28%
What is Tokyo Medical University Hachioji Medical Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,324 of 10,443 | 5.1% | 151 | #5619 | |
| Health SciencesDomain | #9,111 of 11,982 | 5.2% | 154 | #7538 |
Each strip is that field’s whole ranked pool, with the notch where Tokyo Medical University Hachioji Medical Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Tokyo Medical University Hachioji Medical Center specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 7.5× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 22.1 works7.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.
- Medicine 4.1×
- Immunology and Microbiology 3.8×
- Pharmacology, Toxicology and Pharmaceutics 2.6×
- Neuroscience 1.6×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Psychology 1.1×
- Health Professions 0.6×
- Dentistry 0.4×
- Nursing 0.2×
- Chemistry 0.2×
- Earth and Planetary Sciences 0.2×
- Veterinary 0.1×
- Economics, Econometrics and Finance 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Physics and Astronomy 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.0×
- Computer Science 0.0×
- Decision Sciences 0.0×
Who are the top researchers at Tokyo Medical University Hachioji Medical Center?
Ranked on the composite score, Yukio Ikeda, Masaharu Yoshida and Takayoshi Yokoyama lead among researchers whose main affiliation is Tokyo Medical University Hachioji Medical Center.
- 1 Yukio Ikeda Japan · #273,190 worldwide 159 citations · 75 works
- 2 Masaharu Yoshida Japan · #330,525 worldwide 27 citations · 25 works
- 3 Takayoshi Yokoyama Japan · #648,285 worldwide 31 citations · 18 works
- 4 Hidetaka Noma Japan · #651,474 worldwide 45 citations · 20 works
- 5 Asashi Tanaka Japan · #727,453 worldwide 18 citations · 16 works
- 6 K Kozaki Japan · #775,505 worldwide 22 citations · 24 works
- 7 Minoru Endo Japan · #882,145 worldwide 8 citations · 20 works
- 8 M Kozaki Japan · #923,832 worldwide 7 citations · 17 works
- 9 Munehide Nakatsugawa Japan · #950,354 worldwide 52 citations · 18 works
- 10 Koichi Tomita Japan · #1,117,625 worldwide 21 citations · 24 works
Which keywords describe research at Tokyo Medical University Hachioji Medical Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Chemotherapy, Surgical Management, Management, Inflammation, Atherosclerosis and Guidelines.
- Juvenile Idiopathic Arthritis
- Immune Checkpoint Blockade
- Cholangiocarcinoma
- Revascularization
- Pathophysiology
- Choroidal Thickness
- Magnetic Resonance Imaging
- Vascular Endothelial Growth Factor
- Immunity
- Glomerular Diseases
- Percutaneous Coronary Intervention
- Complications
- Genetics
- Radiotherapy
- Clinical Practice Guidelines
- Immunotherapy
- Guidelines
- Treatment
- Chemotherapy
- Inflammation
- Epidemiology
- Diagnosis
- Management
- Surgical Management
- Atherosclerosis
- Prognostic Factors
- Tumor Microenvironment
- Rituximab
- Macular Degeneration
- Diabetic Retinopathy
- Surgery
- Nephrotic Syndrome
- Prognosis
- Immunosuppressive Therapy
- ACE2 Receptor
- Intravitreal Injection
- Retinal Pigment Epithelium
- Neoadjuvant Therapy
- Coronary Artery Disease
- PD-1 and PD-L1
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology20▲ 2.6×55 topics
- Inflammation11▲ 2.8×22 topics
- Diagnosis10▲ 5.7×25 topics
- Chemotherapy8▲ 6.2×16 topics
- Management8▲ 5.4×14 topics
- Treatment8▲ 3.4×24 topics
- Surgical Management7▲ 8.9×14 topics
- Guidelines7▲ 7.4×9 topics
- Atherosclerosis6▲ 12×4 topics
- Immunotherapy6▲ 4.8×13 topics
- Prognostic Factors6▲ 7.5×12 topics
- Clinical Practice Guidelines6▲ 5.9×12 topics
- Tumor Microenvironment6▲ 6.9×6 topics
- Radiotherapy5▲ 7.2×8 topics
- Rituximab5▲ 17×4 topics
- Genetics5▲ 3.6×8 topics
- Macular Degeneration5▲ 20×3 topics
- Complications4▲ 4.7×13 topics
- Diabetic Retinopathy4▲ 23×2 topics
- Percutaneous Coronary Intervention4▲ 17×4 topics
- Surgery4▲ 6.4×7 topics
- Glomerular Diseases4▲ 66×1 topic
- Nephrotic Syndrome4▲ 66×1 topic
- Immunity4▲ 5.3×5 topics
- Prognosis4▲ 6.5×8 topics
- Vascular Endothelial Growth Factor4▲ 25×2 topics
- Immunosuppressive Therapy4▲ 11×5 topics
- Magnetic Resonance Imaging4▲ 7.8×4 topics
- ACE2 Receptor4▲ 7.9×3 topics
- Choroidal Thickness4▲ 36×1 topic
- Intravitreal Injection4▲ 28×2 topics
- Pathophysiology4▲ 6.5×8 topics
- Retinal Pigment Epithelium4▲ 36×1 topic
- Revascularization4▲ 13×3 topics
- Neoadjuvant Therapy4▲ 7.9×5 topics
- Cholangiocarcinoma4▲ 23×2 topics
- Coronary Artery Disease4▲ 16×2 topics
- Immune Checkpoint Blockade3▲ 16×1 topic
- PD-1 and PD-L13▲ 16×1 topic
- Juvenile Idiopathic Arthritis3▲ 34×2 topics
Which research topics does Tokyo Medical University Hachioji Medical Center publish most on?
By volume in 2022–2025: Renal Diseases and Glomerulopathies, Retinal Diseases and Treatments, Cancer Immunotherapy and Biomarkers and Coronary Interventions and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Renal Diseases and Glomerulopathies Nephrology 4 works
- 2 Retinal Diseases and Treatments Ophthalmology 4 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 4 Coronary Interventions and Diagnostics Surgery 3 works
- 5 Vasculitis and related conditions Pulmonary and Respiratory Medicine 3 works
- 6 Ocular Diseases and Behçet’s Syndrome Ophthalmology 3 works
- 7 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 2 works
- 8 Peripheral Artery Disease Management Surgery 2 works
- 9 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 2 works
- 10 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tokyo Medical University Hachioji Medical Center's research output changed?
Output in 2018–2022 was 21% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.